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Abstract Amyotrophic lateral sclerosis (ALS) and
frontotemporal dementia (FTD) are two neurodegenerative
diseases in which similar pathogenic mechanisms are in-
volved. Both diseases associate to the high propensity of spe-
cific misfolded proteins, like TDP-43 or FUS, to mislocalize
and aggregate. This is partly due to their intrinsic biophysical
properties and partly as a consequence of failure of the neuro-
nal protein quality control (PQC) system. Several familial
ALS/FTD cases are linked to an expansion of a repeated
G4C2 hexanucleotide sequence present in theC9ORF72 gene.
The G4C2, which localizes in an untranslated region of the
C9ORF72 transcript, drives an unconventional repeat-
associated ATG-independent translation. This leads to the syn-
thesis of five different dipeptide repeat proteins (DPRs), which
are not Bclassical^ misfolded proteins, but generate aberrant
aggregation-prone unfolded conformations poorly removed
by the PQC system. The DPRs accumulate into p62/
SQSTM1 and ubiquitin positive inclusions. Here, we analyzed
the biochemical behavior of the five DPRs in immortalized
motoneurons. Our data suggest that while the DPRs are main-
ly processed via autophagy, this system is unable to fully clear
their aggregated forms, and thus they tend to accumulate in
basal conditions. Overexpression of the small heat shock pro-
tein B8 (HSPB8), which facilitates the autophagy-mediated
disposal of a large variety of classical misfolded aggregation-
prone proteins, significantly decreased the accumulation of
most DPR insoluble species. Thus, the induction of HSPB8
might represent a valid approach to decrease DPR-mediated
toxicity and maintain motoneuron viability.
Keywords RAN translation . Protein aggregation . Protein
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Introduction
Amyotrophic lateral sclerosis (ALS) is a motoneuron disease
(MND) in which upper motoneurons of the brain motor cortex
and lower motoneurons of the bulbar region and of the ante-
rior horn of the spinal cord are primarily, but not exclusively,
affected. ALS may associate to other clinical conditions that
diverge from pure MNDs and are typical features of other
neurodegenerative diseases (NDs), like frontotemporal de-
mentia (FTD). The presence of different mixed phenotypes
(e.g., primarily MNDs with some FTD or vice versa) in
ALS and FTD suggests similar pathogenic mechanisms
(Ash et al. 2013; DeJesus-Hernandez et al. 2011; Ferrari
et al. 2011; Renton et al. 2011). In fact, sporadic (sALS) or
familial (fALS) forms of ALS exist, and some proteins mutat-
ed in fALS (like TAR DNA-binding protein 43 (TDP-43) and
FUS RNA binding protein (FUS)) also have aberrant bio-
chemical behaviors in sALS, even in their wild type (wt)
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forms. Some of these proteins are involved into pure familial
(fFTD) or sporadic (sFTD) FTD or to mixed ALS/FTD forms
(Robberecht and Philips 2013). Examples are mutant or wt
TDP-43 or FUS, which tend to mislocalize from the nucleus
to the cytoplasm, where they aggregate (Aulas and Vande
Velde 2015; Mackenzie et al. 2010) and are hallmarks of
ALS and FTD (Taylor et al. 2016). TDP-43 and FUS aggre-
gations are due to their high propensity to misfold and to their
poor removal via the neuronal protein quality control (PQC)
system (Carra et al. 2012; Crippa et al. 2013a; Crippa et al.
2016b; Crippa et al. 2013b; Galbiati et al. 2014). Improved
PQC system activity counteracts their aggregation in neuronal
cells, thereby reducing toxic effect (Williams et al. 2006).
Recently, several fALS and fFTD forms have been linked to
an abnormal expansion of a hexanucleotide repeat of
GGGGCC (G4C2) of the C9ORF72 gene (DeJesus-
Hernandez et al. 2011; Renton et al. 2011). The G4C2 tran-
script accumulates in nuclear RNA foci sequestering RNA-
binding proteins (RBPs), thereby reducing their function
(Peters et al. 2015; Rossi et al. 2015). At the same time, the
expandedG4C2, which is located in the 5′-untranslated region
of the C9ORF72 transcript, serves as template for an uncon-
ventional Brepeat-associated ATG-independent^ translation
(RAN translation) (Ash et al. 2013; Cleary and Ranum
2013; Lashley et al. 2013; Mann et al. 2013; Mori et al.
2013a; Mori et al. 2013b). RAN translation of the expanded
G4C2 (and its antisense C4G2) produces five different dipep-
tide repeat proteins (DPRs): poly Gly-Ala (polyGA), poly
Gly-Pro (polyGP), poly Gly-Arg (polyGR), poly Pro-Arg
(polyPR), and poly Pro-Ala (polyPA) (Mann et al. 2013;
Mori et al. 2013a; Mori et al. 2013b). None of these dipeptides
exist in normal individuals, and it is likely that DPRs exist in
partially structured or metastable conformations. Indeed, they
accumulate in inclusions in neurons and glia of ALS and/or
FTD patients (Ash et al. 2013; Mann et al. 2013; Mori et al.
2013b). Interestingly, these DPR inclusions localize in the
cytoplasm or in the nucleus of affected neurons (Freibaum
and Taylor 2017), and sequester the SQSTM1/p62 autophagy
receptor (Al-Sarraj et al. 2011), but are negative for TDP-43
even if the patients display a typical TDP-43 pathology
(Freibaum and Taylor 2017). This suggests that they are iden-
tified by the PQC system for clearance, but the process may
have failed. It is still highly debated which DPR is more toxic,
and whether particular species may be responsible for neuro-
nal alteration in ALS/FTD. A detailed analysis of the bio-
chemical properties and the potential adverse effects of the
single DPRs has been recently published by Freibaum and
Taylor (2017). However, how these DPRs are recognized by
and/or escape from the PQC system to aggregate is still un-
known, and possibly, boosting the PQC might facilitate their
removal, thereby reducing their toxicity.
Heat shock protein B8 (HSPB8) is a small heat shock
protein (sHSP), which has been found mutated in specific
forms of motor neurophaty (Ghaoui et al. 2016; Irobi
et al. 2004; Tang et al. 2005), and it is highly expressed
in anterior horn spinal cord motoneurons that survive in
ALS mice at end stage of disease (Crippa et al. 2010a;
Crippa et al. 2010b). HSPB8 has been shown to be par-
ticularly active in the removal of aggregating misfolded
TDP-43 (Crippa et al. 2016a; Crippa et al. 2016b).
HSPB8 acts as a chaperone and, in complex with Bcl-2
associated athanogene 3 (BAG3), HSP70 (and CHIP) rec-
ognizes misfolded TDP-43 species (Carra 2009; Carra
et al. 2008b). Once bound to the HSPB8–BAG3–HSP70
complex, misfolded and aggregate-prone TDP-43 species
are targeted to autophagic degradation (Crippa et al.
2010a; Crippa et al. 2010b). This process also requires
an active dynein-mediated retrograde transport, which me-
dia tes the targe t ing of the bound cargo to the
autophagosomes for clearance (Cristofani et al. 2017).
The pro-degradative activity of HSPB8 is not limited to
TDP-43, but it is exerted also on a number of other mu-
tated proteins linked to neurodegenerative diseases.
Examples include mutant SOD1 linked to some fALS
(Crippa et al. 2010b); polyglutamine (polyQ) containing
proteins like androgen receptor (ARpolyQ) and huntingtin
(HTT) (Carra et al. 2008a; Giorgetti et al. 2015; Rusmini
et al. 2013), causing spinal and bulbar muscular atrophy
(SBMA) and Huntington’s disease (HD), respectively;
beta-amyloid (A-beta) linked to Alzheimer disease (AD)
(Wilhelmus et al. 2006); alpha-synuclein (alpha-syn)
causing Parkinson’s disease (PD) (Bruinsma et al. 2011);
and other misfolded proteins such as mutated HSPB5
causing neuropathy (Arndt et al. 2010; Chavez Zobel
et al. 2003; Sanbe et al. 2009; Vicart et al. 1998).
Collectively, these data demonstrate that, in mammalian
cells, HSPB8 is able to recognize and interact with a large
variety of misfolded protein conformations, avoiding their
irreversible aggregation and promoting their autophagy-
mediated disposal.
Here, we investigated whether the potent autophagy facil-
itator HSPB8 decreases the aggregation propensity of the five
DPRs and decreases their accumulation, comparing its effica-
cy on the five different DPRs. Collectively, our data demon-
strated that the activity of HSPB8 is not limited to classical
misfolded proteins, but extends in cells to a large variety of
aberrant peptides that may generate aggregating species.
Methods
Chemicals
The chemicals used were Z-Leu-Leu-Leu-al (MG132)
(Sigma-Aldrich, C2211) and 3-methyladenine (3-MA)
(Selleckchem, S2767).
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Plasmids and siRNA
The FLAG-tagged plasmids coding for FLAG-polyGA,
FLAG-polyGP, FLAG-polyGR, FLAG-polyPR, and FLAG-
polyPA were kindly provided by Prof. Daisuke Ito (Keio
University School of Medicine). All plasmids code 100 re-
peats for each DPRs (Yamakawa et al. 2015). pCI-HSPB8
plasmid is routinely used in our laboratory and it has been
previously described (Crippa et al. 2010b; Rusmini et al.
2013). pcDNA3 (Life Technologies, V790-20) plasmid was
used to normalize for transfected plasmid DNA amount.
pEGFPN1 (Clontech Lab, U55762) plasmid was used to eval-
uate transfection efficiency by fluorescent microscopy.
To silence endogenous HspB8 expression, we used a cus-
tom small interfering RNA (siRNA) duplex (HspB8 target
sequence: CGG AAG AGC UGA UGG UAA AUU; non-
target target sequence: UAG CGA CUA AAC ACA UCA
AUU) (Dharmacon, Thermo Scientific Life Sciences).
Cell cultures and transfection
The immortalized motoneuronal cell line NSC34 is routinely
used in our laboratory (Crippa et al. 2010a, 2010b; Piccioni
et al. 2002; Rusmini et al. 2011; Simeoni et al. 2000) and has
been transfected with Lipofectamine (Life Technologies,
18324020)/transferrin (Sigma-Aldrich, T8158), as previously
described (Crippa et al. 2016b; Giorgetti et al. 2015), using
0.6 μg of plasmid DNA, 4 μL of transferrin solution, and 2 μL
of Lipofectamine (for well of 12-well plate). siRNA transfec-
tion was performed with Lipofectamine 2000 (Life
Technologies, 11668019) using 40 pmol of target RNA and
following manufacturer’s instructions.
Microscopy analyses
NSC34 cells were plated in 24-well multiwell plates contain-
ing coverslips at 35,000 cells/well density, transiently
transfected with the plasmid coding for FLAG-DPRs as pre-
viously described. Then, the cells were fixed and processed as
previously described (Sau et al. 2007). The following primary
antibodies were used to analyze protein distributions: mouse
monoclonal ANTI-FLAG M2 (dilution 1:500; Sigma,
F3165), homemade rabbit polyclonal anti-HSPB8 no. 3 (dilu-
tion 1:200), and homemade rabbit polyclonal anti-human
HSPB8 no. 25 (dilution 1:200). All antibodies were diluted
in TBS-T containing 5% nonfat dried milk powder
(Euroclone, EMR180500). Secondary antibodies were as fol-
lows: Alexa Fluor 488 anti-mouse (dilution 1:1,000; Life
Technologies, A11017) and Alexa Fluor 594 anti-rabbit (dilu-
tion 1:2,000; Life Technologies, A11072) in TBS-T contain-
ing 5% nonfat dried milk powder (Euroclone, EMR180500).
Cells were stained with Hoechst to visualize the nuclei.
Images were acquired with LSM510 Meta system confocal
microscope (Zeiss, Oberkochen, Germany). Images were
processed with the Aim 4.2 software (Zeiss).
WB analysis and FRA
NSC34 cells were plated in 12-well plates at 80,000 cell/
well (three wells for each condition to be tested; n = 3).
Cells were transfected, as described above, 24 h after plat-
ing. In experiments involving autophagy blockage, 10 mM
3-MAwas added to the cells for the last 48 h prior to protein
extraction. Proteasome inhibition was performed by adding
10 μM MG132 treatment for the last 16 h (overnight treat-
ment). Cells were harvested and centrifuged 5 min at 100×g,
72 h after plating, at 4 °C; the cell pellets were re-suspended
in PBS (Sigma-Aldrich, P4417) added of the protease inhib-
itor cocktail (Sigma-Aldrich, P8340) and homogenized
using slight sonication to lyse cells and nuclei as previously
described (Crippa et al. 2016a; Crippa et al. 2016b; Giorgetti
et al. 2015; Rusmini et al. 2013). Total proteins were deter-
mined with the bicinchoninic acid method (BCA assay;
Euroclone, EMP014500).
Western blot (WB) was performed on 10% SDS–poly-
acrylamide gel electrophoresis loading 20 μg of total pro-
tein extracts. Samples were then electro-transferred to ni-
trocellulose membrane (Bio-Rad 1620115) using a trans-
Blot apparatus (Mini Trans-Blot Cel l ; Bio-Rad
Laboratories). The membranes were treated with a
blocking solution containing 5% nonfat dried milk pow-
der (Euroclone, EMR180500) in Tris-buffered saline with
Tween 20 (0.01%) (TBS-T; Tris base 20 mM, NaCl
140 mM, pH 7.6) for 1 h and then incubated with one
of the following primary antibodies: (a) mouse polyclonal
ANTI-FLAG M2 (dilution 1:1000; Sigma-Aldrich,
F1804) to detect DPRs; (b) mouse monoclonal anti-
TUBA (dilution 1:4000; Sigma-Aldrich, T6199); and (c)
homemade rabbit polyclonal anti-HSPB8 no. 25 (Carra
et al. 2008a; Carra et al. 2005) (dilution 1:3000).
Immunoreactivity was detected using the following sec-
ondary peroxidase-conjugated antibodies: goat anti-rabbit
(dilution 1:10,000; Santa Cruz Biotechnology, sc-2004)
and goat anti-mouse (dilution 1:10,000; Santa Cruz
Biotechnology, sc-2005). Signals were revealed by chemi-
luminescence detection kit reagents (Clarity™ Western
ECL Blotting Substrate; Bio-Rad, 170-5060). The same
membranes were subsequently processed with different
antibodies to detect the levels of different proteins in the
same sample, after stripping for 20 min at room tempera-
ture (StripABlot; Euroclone, EMP100500). Filter retarda-
tion assay (FRA) was performed using a Bio-Dot SF
Microfiltration Apparatus (Bio-Rad). Eight micrograms
of the total proteins were filtered through a 0.2-μm cellu-
lose acetate membrane (Whatman, 100404180). The
membranes were probed as described for WB.
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A ChemiDoc XRS System (Bio-Rad) was used for the
image acquisition ofWB and FRA. Optical density of samples
assayed withWB or FRAwas detected and analyzed using the
Image Lab software (Bio-Rad). Statistical analyses have been
performed using the relative optical densities defined as the
ratio between the optical densities of each independent bio-
logical sample (n = 3) and the mean optical density of control
samples.
Statistical analysis
Data are presented as mean ± SD. Statistical analyses
have been performed by using one-tailed unpaired
Student’s t test to compare data between two groups and
one-way ANOVA to compare more than two groups of
data. When ANOVA resulted significant, we performed
the Tukey’s post hoc test (and one-tailed unpaired
Student’s t test when the variances between groups were
highly different) (see figure legends for details) for mul-
tiple comparisons. Computations were done with the
PRISM (ver. 6.0 h) software (GraphPad Software, La
Jolla, CA, USA).
Results
Biochemical characterization of DPRs in immortalized
motoneurons
To evaluate the biochemical behavior of the DPRs deriving
from RAN translation of the G4C2 of the C9ORF72 tran-
script, we used artificial cDNAs expressing each single
flagged DPR under the control of the CMV promoter. We kept
neuronal cell growth and transfection conditions identical for
all plasmids carrying the five different DPR-encoding se-
quences in order to ensure DPR identical expression. We ini-
tially tested in immortalized motoneurons the level of the five
DPRs by immunofluorescence (IF), WB, and FRA using an
anti-FLAG antibody. Fig. 1a illustrates the IF analysis, which
revealed that the five DPRs have very different intracellular
localization and aggregation propensity. In fact, polyGAwas
uniformly distributed into the entire cytoplasm of motoneuro-
nal cell, with very few detectable small aggregates, while
polyGP and polyPA mainly distributed in peripheral cell re-
gion possibly associated to the cell membranes. Only polyGR
and polyPR were clearly detectable in aggregate form. The
polyGR inclusions mainly localized in the cytoplasm, while
Fig. 1 DPRs overexpression in
NSC34 cells. a Confocal
microscopy analysis of NSC34
cells shows DPRs localization
(×63 magnification); scale bars
30 μm. b, c NSC34 cells were
collected 48 h after transfection
with FLAG-polyDPRs (GA, GP,
GR, PR, PA). bWB shows DPR
total levels. TUBAwas used as
loading control. c FRA shows
PBS insoluble fraction of DPRs.
Bar graph represents the FRA
mean relative optical density
computed over three independent
biological samples for each con-
dition (n = 3) ± SD (**p < 0.01,
***p < 0.001; one-way ANOVA
followed by Tukey’s test)
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the polyPR inclusions were confined into the cell nucleus. By
analyzing DPR levels inWB, we found that their SDS-soluble
monomeric forms considerably varied, being very high for the
polyGP, moderate for the polyPA, low for polyPR, and absent
for polyGR and polyGA. At longer exposure of the ECL-
processed membrane from WB, a tiny band of polyGA ap-
peared (not shown). Expression of the polyGP resulted in two
proteins with different molecular weight (M.W.) (about 40 and
55 kDa), while that of polyPA was observed at an apparent
M.W. of 95 kDa and polyPR was observed at an apparent
M.W. of 37 kDa (Fig. 1b). It is well known that proteins that
have a high tendency to form aggregates become insoluble
and cannot be detected with conventional WB (Tebbenkamp
and Borchelt 2009). These aggregated species are instead de-
tected with FRA (Carra et al. 2008a; Crippa et al. 2010b;
Rusmini et al. 2013). We then analyzed by FRAwhether the
DPR species that are not detected by conventional WB, such
as polyGA, polyGR, and polyPR, would instead accumulate
in the form of aggregated species. In line with our hypothesis,
the highest amount of PBS-insoluble material was found in
lysates of motoneurons expressing the polyGA, polyPR, and
polyGR, which were undetected or only moderately detected
byWB (Fig. 1c). Conversely, polyGP and polyPAwere main-
ly accumulated in form of SDS-soluble species and only poor-
ly accumulated in form of PBS-insoluble species in motoneu-
rons (Fig. 1b, c). These data indicate the existence of an in-
verse correlation between solubility and accumulation into
insoluble aggregates of the five DPRs. We thus analyzed
whether the different biochemical properties of the DPRs
may relate to their selective intracellular processing by the
PQC system. We selectively blocked autophagy or protea-
some with the inhibitors 3-MA and MG132 respectively. We
focused on the total levels of insoluble materials, which cor-
respond to the species that accumulate probably due to an
inefficient removal by the PQC system. The data suggested
that the various DPRs are differentially degraded by these two
alternative systems. In fact, autophagy blockage performed
using the inhibitor 3-MA resulted in a significant increased
of the insoluble fractions of most DPRs, except for polyPR
(Fig. 2a). The levels of insoluble polyGA were increased ca.
2.5-folds by autophagy blockage. A similar effect was ob-
served for polyPA (which also contains the hydrophobic ami-
no acid alanine), although its soluble and insoluble levels are
very low compared to the other DPRs. Interestingly, these two
Fig. 2 Effect of autophagy and proteasome inhibitors on the PBS
insoluble levels of DPRs. NSC34 cells were collected 48 h after
transfection with FLAG-polyDPRs (GA, GP, GR, PR, PA). a FRA
shows PBS insoluble fraction of DPRs after 48 h of autophagy
inhibition treatment with 10 mM 3-MA. Bar graph represents the FRA
mean relative optical density computed over three independent biological
samples for each condition (n = 3) ± SD (*p < 0.05, **p < 0.01,
***p < 0.001; Student’s t test). b FRA shows PBS insoluble fraction of
DPRs after 16 h of proteasome inhibition treatment with 10 μMMG-132.
Bar graph represents the FRA mean relative optical density computed
over three independent biological samples for each condition
(n = 3) ± SD (***p < 0.001; Student’s t test)
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DPRs have a very different biochemical behavior in basal
condition, since polyGA has the highest tendency to aggre-
gate, while polyPA poorly aggregates and mainly exists in
PBS soluble forms (see Fig. 1b, c). Moreover, both insoluble
polyGA and polyPA accumulate when autophagosome forma-
tion is inhibited; in basal condition, only the polyGA remains
present in large insoluble amounts in motoneuronal cells; it is
likely that these DPRs (but not the polyPA) might be partially
resistant to clearance using the autophagosome pathway. The
effects of 3-MAwere even more robust on the DPRs contain-
ing glycine; in fact, polyGP and polyGR, we noted, respec-
tively, ca. 5- and 3.5-fold increases when autophagosome for-
mation was inhibited with 3-MA (Fig. 2a). Notably, while in
basal condition (see Fig. 1c), polyGP poorly aggregates,
polyGR forms large amounts of PBS-insoluble materials.
Therefore, the presence of a proline instead of an arginine,
together with the glycine, significantly modified the capability
of these DPRs to be removed using autophagy. Instead, the
clearance was almost complete for the polyGP and only mod-
erate for the polyGR. Similar results were observed for the
other DPR containing arginine. In contrast, the polyPR, which
exists both in PBS-soluble and insoluble forms, apparently is
not processed utilizing the autophagic system on our moto-
neuronal cells; in fact, we found very high levels of polyPR
accumulating in basal condition (Fig. 1c), which were not
modified by 3-MA (Fig. 2a). Collectively, these results sug-
gest that autophagy participates to the clearance of DPRs,
except for polyPR.
Concerning the contribution of the proteasome in the re-
moval of DPRs, we found that only polyGP insoluble species
were significantly accumulated following proteasome inhibi-
tion (Fig. 2b). Instead, the insoluble levels of the other four
DPRs remained unchanged before and after MG132 treat-
ment. In combination, these data show that in immortalized
motoneurons, polyGP is the only DPR processed by both
degradative systems, while the other mainly relies on func-
tional autophagy.
Upregulation of HSPB8 decreases the accumulation
of DPRs
Previous studies, including ours, demonstrated that HSPB8
can recognize a number of misfolded proteins associated to
neurodegenerative conditions (ARpolyQ, HTT, mutant
SOD1, TDP-43 and its disease-associated fragments, A-beta,
alpha-syn) (Bruinsma et al. 2011; Carra et al. 2008a; Crippa
et al. 2010a; Crippa et al. 2010b; Giorgetti et al. 2015;
Rusmini et al. 2013;Wilhelmus et al. 2006), and even proteins
unrelated to NDs (Arndt et al. 2010; Chavez Zobel et al. 2003;
Sanbe et al. 2009). HSPB8, acting in concert with the BAG3-
HSP70 machinery, facilitates the autophagic removal of
misfolded proteins. Our biochemical characterization showed
that polyGA, polyGR, and polyPR mainly accumulate in the
PBS-insoluble fraction; moreover, except for polyPR, whose
levels are unchanged upon autophagy inhibition, the other
four DPRs analyzed are all cleared by autophagy. Here, we
analyzed whether HSPB8 can also recognize the RAN trans-
lated Baberrant^ DPR species that cannot be considered
Bmisfolded proteins^ and normally do not exist in cells, facil-
itating their autophagy-mediated clearance.
To this purpose, we upregulated or silencedHSPB8 expres-
sion in immortalized motoneurons expressing each single
DPR and wemeasured the variation of aggregates of insoluble
material in IF and FRA, respectively. Figure 3 shows that
HSPB8 overexpression fully removes all five detectable
DPRs from cells, independently from their intracellular local-
ization or aggregated status. In fact, both the soluble cytoplas-
mic polyGA and the two aggregated polyGR and polyPR
species disappeared in cells overexpressing HSPB8. Also,
the membrane associated polyGP and polyPA DPRs were
undetectable in the presence of overexpressed HSPB8. In line
with the IF analysis, the data obtained with FRA, reported in
Fig. 4a, clearly demonstrated that increased levels of HSPB8
greatly reduced the accumulation of insoluble species formed
by all DPRs. The effect of HSPB8 was particularly pro-
nounced on polyGA, polyGR, and polyPR, for which the
removal of insoluble DPR species was almost complete, even
if these DPRs accumulated at very high levels in NSC34 cells
(see Fig. 1). PolyGP and polyPA are already actively proc-
essed by autophagy in basal condition (see Figs. 1c and 2b);
thus, the pro-autophagic facilitation exerted by HSPB8 was
slightly less evident for these DPRs. Notably, HSPB8 also
decreased the total PBS-soluble levels of the various DPRs,
measured by WB, except for PBS-soluble polyGR that is al-
most undetectable (Fig. 4b).
We then downregulated HSPB8 expression using a specific
siRNA (Fig. 5c). The IF analysis indicated that HSPB8 silenc-
ing resulted in an increased number of DPR positive cells,
without affecting distribution and localization in a measurable
manner (data not shown), since IF is not quantitative to eval-
uate the effect of HSPB8. By measuring its effects on the
levels of accumulation of PBS-soluble and insoluble DPR
species we found that the levels of insoluble polyGA,
polyGP, and polyPA (although the latter accumulating at low-
er levels) species formed inNSC34 cells were increased by the
removal of endogenous HSPB8 (Fig. 5a). Insoluble polyGR
species, which significantly increased after autophagy block-
age (Fig. 2a), also tended to increase when HSPB8 is silenced,
without reaching a statistical significance (Fig. 5a).
Conversely, polyPR remained unchanged both after autopha-
gy blockage (Fig. 2a) and HSPB8 dowregulation (Fig. 5a). It
is likely that the endogenous HSPB8 levels are not sufficient
to clear polyPR aggregates from motoneuronal cells via au-
tophagy. However, exogenously expressed HSPB8 (at higher
levels) greatly facilitated autophagic clearance of polyPR sol-
uble and insoluble species (see Fig. 4). Thus, polyPR, which
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has a high tendency to aggregate (Fig. 1c), could readily ac-
cumulate in PBS-insoluble forms that are less efficiently de-
graded by autophagy. Increasing the expression of HSPB8
might keep polyPR in a state competent for clearance, as it
occurs following overexpression of HSPB8 (Fig. 4). Notably,
with HSPB8 silencing, we did not find an increase of the
soluble levels of DPRs in WB (Fig. 5b), suggesting that the
endogenous HSPB8would act primarily on the insoluble DPR
species. Instead, upon HSPB8 overexpression, both soluble
and insoluble DPR species significantly decreased in immor-
talized motoneurons. In combination, these results suggest that
overexpressed HSPB8may keep all DPRs in a state competent
for disposal by the cells, avoiding their aggregation.
Discussion
In this study, we provide a biochemical characterization of
five different RAN translated DPRs from the C9ORF72 tran-
script containing an expanded G4C2 stretch in immortalized
motoneuronal cells. Since DPRs cannot be considered as clas-
sical misfolded proteins, but likely generate abnormal struc-
tures uncommon for neuronal cells, we also evaluated whether
HSPB8, a chaperone able to enhance misfolded protein au-
tophagic clearance, was active on the five DPRs.
We found that the five DPRs have a very different locali-
zation and propensity to accumulate in immortalized moto-
neurons. Formation of insoluble material was very low for
the polyGP and polyPA DPRs, which seems to be processed
via autophagy; instead, the three remaining DPRs analyzed
showed a very high tendency to accumulate in form of insol-
uble species. Interestingly, the polyGP and polyPA are un-
charged DPRs with a compact flexible coil structure (Lee
et al. 2016). The solubility data that we obtained are generally
in line with a previous report from Yamakawa et al. (2015),
even if in this study, differences were reported by using alter-
native cell lines (N2a and 293T cells). Concerning the pre-
ferred pathway of degradation, this was not uniform for the
five DPRs. Of all five DPRs, only the polyGP seems to be
efficiently removed via the proteasome, while the others are
apparently mainly degraded via autophagy, except for
polyPR, which is not significantly affected by 3-MA treatment
or HSPB8 depletion. Since polyPR inclusions are mostly de-
tectable in the nucleus, it is possible that they cannot be
cleared by autophagy, which is exclusively a cytoplasmic pro-
cess. The fact that HSPB8 is active also on this DPR in basal
condition suggests that the action of this chaperone may take
place before polyPR nuclear import and aggregation. Despite
their different localization, all DPRs clearance was enhanced
by HSPB8. Instead, in N2a and 293T cells, also polyGR and
polyPR can be cleared via this pathway (Yamakawa et al.
2015). In combination, these results suggest that different
mammalian cell lines differentially use both degradative path-
ways to clear the DPRs. Although the proteasome or
autophagy-mediated clearance of the five DPRs seems to vary
based on the cell type used, at least in motoneuronal cells, the
presence of proline only with glycine (in polyGP), and not
Fig. 3 Effect of HSPB8 overexpression on DPRs distribution. NSC34
cells were fixed 48 h after transfection with FLAG-polyDPRs (GA, GP,
GR, PR, PA) and pCI-HSPB8 or pcDNA3. IF shows DPRs distribution
(×63 magnification); scale bars 30 μm
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with arginine or alanine (in polyPR and polyPA, respectively)
correlates with the utilization of the proteasome pathway rath-
er than the autophagic pathway for clearance.Whether it is the
type of amino acid or rather the differential tendency to form
oligomeric aggregation-prone species that influences the path-
way that is mainly degrading one specific type of DPR will
require future investigations.
Next, we tested the effects of upregulation and downregu-
lation of HSPB8 on DPRs accumulation and clearance in mo-
toneurons. The selection of HSPB8 was based on the follow-
ing reasons: (1) as previously mentioned, HSPB8 was shown
to enhance the autophagy-mediated clearance of a large vari-
ety of aggregation-prone proteins associated with motoneuron
and neurodegenerative diseases (Carra et al. 2013; Crippa
et al. 2013b; Rusmini et al. 2016); (2) HSPB8 is induced in
the motor neuron surviving at late stage of disease in the spinal
cord of SOD1 ALS mice, as well as in patients affected by
ALS (Crippa et al. 2010a; Crippa et al. 2010b); and (3) muta-
tions in the HSPB8 gene lead to motor neuropathy (Evgrafov
et al. 2004; Ikeda et al. 2009; Irobi et al. 2004; Kwok et al.
2011; Tang et al. 2005; Ghaoui et al. 2016). Altogether, these
findings support the interpretation that deregulation in the ex-
pression levels of HSPB8 might render motoneurons more
vulnerable to proteotoxic insults, while its induction might
protect against the toxicity exerted by aggregation-prone spe-
cies, including DPRs, which accumulate with high frequency
in ALS and FTD patients (Al-Sarraj et al. 2011). We found
that HSPB8 overexpression significantly and robustly coun-
teracts the accumulation of insoluble species of all five DPRs.
Exogenously expressed HSPB8 decreased the accumulation
of both aggregating species and the total soluble protein levels
detectable in WB. We noticed that HSPB8 is particular active
in decreasing the levels of those DPRs characterized by an
high propensity to form insoluble species (polyGA, polyGR,
and polyPR), including polyGA, which is the one showing the
strongest propensity to generate Congo red or thioflavin T
positive amyloidogenic fibrils (May et al. 2014; Chang et al.
2016) with a parallel β-sheet structure like those of the beta-
amyloid (Chang et al. 2016; Edbauer and Haass 2016).
Notably, the polyGA has been reported to be less toxic
(Freibaum et al. 2015; Lee et al. 2016; Mizielinska et al.
2014; Wen et al. 2014) than polyGR and polyPR (two highly
charged and polar DPRs, since they contain the arginine ami-
no acid), which are thought to be the most toxic at very low
concentrations.
When we silenced the endogenous expression of HSPB8,
we found a significant increase of insoluble species of three
out of five DPRs (polyGA, polyGP, and polyPA); the effect on
Fig. 4 Effect of HSPB8 overexpression on DPRs levels. NSC34 cells
were collected 48 h after transfection with FLAG-polyDPRs (GA, GP,
GR, PR, PA) and pCI-HSPB8 or pCDNA3. a FRA shows PBS insoluble
fraction of DPRs. Bar graph represents the FRA mean relative optical
density computed over three independent biological samples for each
condition (n = 3) ± SD (**p < 0.01, ***p < 0.001; Student’s t test). b
WB shows DPR total levels; TUBAwas used as loading control
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polyPA was significant, but the total levels of accumulated
material remain low. Conversely, polyGR tended to increase,
even if the variation was not statistically relevant. Instead,
polyPR levels remained unaffected upon depletion of
HSPB8. Interestingly, the downregulation of endogenous
HSPB8 has no effect on the overall soluble levels of the
DPRs, suggesting that in resting cells, HSPB8 would only
target aggregating species, favoring their autophagy-
mediated clearance. This interpretation is supported by the
observation that the only DPR that is poorly processed by
autophagy in motoneurons, namely polyPR, is also the only
one that is not affected by the depletion of HSPB8. Altogether,
the study here reported has shown that HSPB8 recognizes and
facilitates clearance of insoluble species of these peculiar
DPRs, whose structuresmay not reflect those typically formed
by Bclassical^misfolded proteins responsible for neurodegen-
erative diseases. It remains to be determined how HSPB8
recognizes these structures, and whether it acts also on a
mixed pool of the five DPRs or rather it preferentially binds
to the more aggregation-prone species.
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